Biologics for psoriasis patients in the COVID-19 era: more evidence, less fears.

Megna, Matteo; Ruggiero, Angelo; Marasca, Claudio; Fabbrocini, Gabriella

Megna, Matteo; Ruggiero, Angelo; Marasca, Claudio; Fabbrocini, Gabriella.

Megna M; Department of Clinical Medicine and Surgery, Section of Dermatology, University of Naples Federico II, Napoli, Italy.
Ruggiero A; Department of Clinical Medicine and Surgery, Section of Dermatology, University of Naples Federico II, Napoli, Italy.
Marasca C; Department of Clinical Medicine and Surgery, Section of Dermatology, University of Naples Federico II, Napoli, Italy.
Fabbrocini G; Department of Clinical Medicine and Surgery, Section of Dermatology, University of Naples Federico II, Napoli, Italy.

J Dermatolog Treat ; 31(4): 328-329, 2020 06.

Article in English | MEDLINE | ID: covidwho-72163

Subject(s)

Biological Products; Psoriasis; Betacoronavirus; COVID-19; Coronavirus Infections; Fear; Humans; Immunosuppressive Agents; Pandemics; Pneumonia, Viral; SARS-CoV-2

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Psoriasis / Biological Products Limits: Humans Language: English Journal: J Dermatolog Treat Journal subject: Dermatology Year: 2020 Document Type: Article Affiliation country: 09546634.2020.1757605

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google